Suppr超能文献

C 反应蛋白与白蛋白比值是胆囊癌的极佳预后预测指标。

The C-reactive protein to albumin ratio is an excellent prognostic predictor for gallbladder cancer.

机构信息

Department of Hepatopancreatobiliary Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, China.

出版信息

Biosci Trends. 2021 Jan 23;14(6):428-435. doi: 10.5582/bst.2020.03326. Epub 2020 Nov 25.

Abstract

A number of inflammation indicators based on C-reactive protein (CRP) and albumin have been widely used to predict the prognosis in several types of tumors, but their functions in gallbladder cancer (GBC) have rarely been explored. The aim of our study is to evaluate and compare the prognostic values of the C-reactive protein to albumin ratio (CAR), Glasgow prognostic score (GPS), modified Glasgow prognostic score (mGPS) and high-sensitivity modified Glasgow prognostic score (HS-mGPS) in patients with GBC. 144 GBC patients who received curative surgery in our hospital from January 2010 to May 2017 were enrolled in this research. The Kaplan-Meier analysis showed that the median OS of the patients in the high CAR group was significantly shorter than the patients in the low group (p < 0.001), and higher scores of GPS, mGPS and HS-mGPS were also associated with decreased OS, respectively. However, according to the Receiver Operating Characteristic (ROC) curve, the CAR was superior to the other prognostic scores in determining the prognosis for the GBC patients. In the multivariate analysis, CAR was verified as an independent risk factor for poor prognosis, together with tumor differentiation, T stage and postoperative complications. All in all, compared to the other three CRP-albumin-related prognostic predictors, CRA is a better indicator in predicting poor long-term outcomes in GBC patients after radical surgery.

摘要

多项基于 C 反应蛋白(CRP)和白蛋白的炎症指标已被广泛用于预测多种类型肿瘤的预后,但它们在胆囊癌(GBC)中的作用很少被探索。我们的研究旨在评估和比较 C 反应蛋白与白蛋白比值(CAR)、格拉斯哥预后评分(GPS)、改良格拉斯哥预后评分(mGPS)和高敏改良格拉斯哥预后评分(HS-mGPS)在 GBC 患者中的预后价值。本研究纳入了 2010 年 1 月至 2017 年 5 月在我院接受根治性手术的 144 例 GBC 患者。Kaplan-Meier 分析显示,高 CAR 组患者的中位 OS 明显短于低 CAR 组(p<0.001),GPS、mGPS 和 HS-mGPS 评分较高者 OS 也相应降低。然而,根据受试者工作特征(ROC)曲线,CAR 在判断 GBC 患者预后方面优于其他预后评分。多因素分析显示,CAR 与肿瘤分化、T 分期和术后并发症一起是预后不良的独立危险因素。总之,与其他三种 CRP-白蛋白相关预后预测因子相比,CAR 是预测 GBC 患者根治性手术后不良长期结局的更好指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验